Shares of Laboratory Corp. of America Holdings (NYSE:LH) gapped up prior to trading on Thursday . The stock had previously closed at $140.13, but opened at $140.15. Laboratory Corp. of America Holdings shares last traded at $140.81, with a volume of 139,330 shares traded.

LH has been the subject of a number of research analyst reports. Mizuho increased their price target on shares of Laboratory Corp. of America Holdings from $119.00 to $132.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 26th. Barclays PLC increased their price target on shares of Laboratory Corp. of America Holdings from $152.00 to $155.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 26th. Canaccord Genuity raised their price objective on shares of Laboratory Corp. of America Holdings from $135.00 to $140.00 and gave the company a “buy” rating in a research report on Tuesday, April 26th. Jefferies Group raised their price objective on shares of Laboratory Corp. of America Holdings from $121.00 to $131.00 and gave the company a “hold” rating in a research report on Tuesday, April 26th. Finally, Morgan Stanley reaffirmed a “buy” rating on shares of Laboratory Corp. of America Holdings in a research report on Monday, May 2nd. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $138.15.

The stock has a 50 day moving average of $136.08 and a 200 day moving average of $123.06. The company has a market cap of $14.33 billion and a price-to-earnings ratio of 23.25.

Laboratory Corp. of America Holdings (NYSE:LH) last released its quarterly earnings results on Wednesday, July 27th. The company reported $2.31 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.01. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.33 billion. The company’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $2.09 EPS. Analysts expect that Laboratory Corp. of America Holdings will post $8.82 EPS for the current year.

In other news, Director Robert E. Mittelstaedt, Jr. sold 992 shares of the company’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $140.15, for a total transaction of $139,028.80. Following the sale, the director now owns 12,340 shares in the company, valued at approximately $1,729,451. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Lisa J. Uthgenannt sold 1,177 shares of the company’s stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $140.00, for a total value of $164,780.00. Following the sale, the insider now owns 3,660 shares in the company, valued at approximately $512,400. The disclosure for this sale can be found here.

Several large investors recently made changes to their positions in the company. Victory Capital Management Inc. boosted its stake in shares of Laboratory Corp. of America Holdings by 20.2% in the fourth quarter. Victory Capital Management Inc. now owns 9,223 shares of the company’s stock worth $1,140,000 after buying an additional 1,549 shares in the last quarter. Advantus Capital Management Inc boosted its stake in shares of Laboratory Corp. of America Holdings by 3.5% in the fourth quarter. Advantus Capital Management Inc now owns 9,796 shares of the company’s stock worth $1,211,000 after buying an additional 332 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in Laboratory Corp. of America Holdings by 0.5% in the fourth quarter. Mutual of America Capital Management LLC now owns 11,272 shares of the company’s stock worth $1,394,000 after buying an additional 61 shares during the period. Suntrust Banks Inc. boosted its stake in Laboratory Corp. of America Holdings by 17.4% in the fourth quarter. Suntrust Banks Inc. now owns 13,227 shares of the company’s stock worth $1,633,000 after buying an additional 1,963 shares during the period. Finally, Trexquant Investment LP acquired a new stake in Laboratory Corp. of America Holdings during the fourth quarter worth $2,040,000.

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.